Literature DB >> 24750378

Travel-related infection in European travelers, EuroTravNet 2011.

Ben Warne1, Leisa H Weld, Jakob P Cramer, Vanessa K Field, Martin P Grobusch, Eric Caumes, Mogens Jensenius, Philippe Gautret, Patricia Schlagenhauf, Francesco Castelli, David G Lalloo, Johan Ursing, François Chappuis, Frank von Sonnenburg, Rogelio López-Vélez, Christophe Rapp, Kitty C Smith, Philippe Parola, Effrossyni Gkrania-Klotsas.   

Abstract

BACKGROUND: Limited data exist on infectious diseases imported to various locations in Europe, particularly after travel within the continent.
METHODS: To investigate travel-related disease relevant to Europe that is potentially preventable through pre-travel intervention, we analyzed the EuroTravNet database of 5,965 ill travelers reported by 16 centers in "Western" Europe in 2011.
RESULTS: There were 54 cases of vaccine-preventable disease, mostly hepatitis A (n = 16), typhoid fever (n = 11), and measles (n = 8); 6 cases (including 3 measles cases) were associated with travel within "Western" Europe. Malaria was the most commonly diagnosed infection (n = 482, 8.1% of all travel-related morbidity). Among patients with malaria, the military most commonly received pre-travel advice (95%), followed by travelers for missionary, volunteer, research, or aid work (81%) but travelers visiting friends and relatives (VFRs) were least likely to receive pre-travel advice (21%). The vast majority (96%) of malaria patients were resident in "Western" Europe, but over half (56%) were born elsewhere. Other significant causes of morbidity, which could be reduced through advice and behavioral change, include Giardia (n = 221, 3.7%), dengue (n = 146, 2.4%), and schistosomiasis (n = 131, 2.2%). Of 206 (3.5%) travelers with exposure in "Western" Europe, 75% were tourists; the highest burden of disease was acute gastrointestinal infection (35% cases). Travel from "Eastern" Europe (n = 132, 2.2%) was largely associated with migration-related travel (53%); among chronic infectious diseases, tuberculosis was frequently diagnosed (n = 20). Travelers VFRs contributed the largest group of malaria patients (46%), but also had the lowest documented rate of pre-travel health advice in this subset (20%). Overall, 44% of nonimmigrant ill travelers did not receive pre-travel advice.
CONCLUSION: There is a burden of infectious diseases in travelers attending European health centers that is potentially preventable through comprehensive pre-travel advice, chemoprophylaxis, and vaccination. Targeted interventions for high-risk groups such as travelers VFRs and migration-associated travelers are of particular importance.
© 2014 International Society of Travel Medicine.

Entities:  

Mesh:

Year:  2014        PMID: 24750378     DOI: 10.1111/jtm.12120

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  18 in total

1.  Spectrum of Imported Infectious Diseases: A Comparative Prevalence Study of 16,817 German Travelers and 977 Immigrants from the Tropics and Subtropics.

Authors:  Karl-Heinz Herbinger; Martin Alberer; Nicole Berens-Riha; Mirjam Schunk; Gisela Bretzel; Frank von Sonnenburg; Hans Dieter Nothdurft; Thomas Löscher; Marcus Beissner
Journal:  Am J Trop Med Hyg       Date:  2016-02-22       Impact factor: 2.345

Review 2.  Prospects for dengue vaccines for travelers.

Authors:  Sl-Ki Lim; Yong Seok Lee; Suk Namkung; Jacqueline K Lim; In-Kyu Yoon
Journal:  Clin Exp Vaccine Res       Date:  2016-07-29

3.  [Protozoa and protozoan infections of humans in Central Europe].

Authors:  Julia Walochnik; Horst Aspöck
Journal:  Wien Med Wochenschr       Date:  2014-10-23

4.  Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.

Authors:  Parisa Karimi; Brenda M Birmann; Lesley A Anderson; Charlene M McShane; Shahinaz M Gadalla; Joshua N Sampson; Sam M Mbulaiteye
Journal:  Br J Haematol       Date:  2018-04-20       Impact factor: 6.998

5.  Spectrum and burden of neglected tropical diseases observed in an infectious and tropical diseases unit in Florence, Italy (2000-2015).

Authors:  Lorenzo Zammarchi; Iacopo Vellere; Leonardo Stella; Filippo Bartalesi; Marianne Strohmeyer; Alessandro Bartoloni
Journal:  Intern Emerg Med       Date:  2017-01-04       Impact factor: 5.472

Review 6.  Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.

Authors:  Benjamin J Visser; Rosanne W Wieten; Daniëlle Kroon; Ingeborg M Nagel; Sabine Bélard; Michèle van Vugt; Martin P Grobusch
Journal:  Malar J       Date:  2014-11-26       Impact factor: 2.979

7.  Chikungunya virus infections among travellers returning to Spain, 2008 to 2014.

Authors:  Maria Dolores Fernandez-Garcia; Mathieu Bangert; Fernando de Ory; Arantxa Potente; Lourdes Hernandez; Fatima Lasala; Laura Herrero; Francisca Molero; Anabel Negredo; Ana Vázquez; Teodora Minguito; Pilar Balfagón; Jesus de la Fuente; Sabino Puente; Eva Ramírez de Arellano; Mar Lago; Miguel Martinez; Joaquim Gascón; Francesca Norman; Rogelio Lopez-Velez; Elena Sulleiro; Diana Pou; Nuria Serre; Ricardo Fernández Roblas; Antonio Tenorio; Leticia Franco; Maria Paz Sanchez-Seco
Journal:  Euro Surveill       Date:  2016-09-08

8.  Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study.

Authors:  Christof D Vinnemeier; Camilla Rothe; Benno Kreuels; Marylyn M Addo; Sabine Vygen-Bonnet; Jakob P Cramer; Thierry Rolling
Journal:  Malar J       Date:  2017-01-25       Impact factor: 2.979

9.  Self-reported infections during international travel and notifiable infections among returning international travellers, Sweden, 2009-2013.

Authors:  Viktor Dahl; Anders Wallensten
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

10.  Mosquitoes on a plane: Disinsection will not stop the spread of vector-borne pathogens, a simulation study.

Authors:  Luis Mier-Y-Teran-Romero; Andrew J Tatem; Michael A Johansson
Journal:  PLoS Negl Trop Dis       Date:  2017-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.